A. Committee:-zackie-achmat, C. Bailey, K. De-cock, W. El-sadr, K. Freedberg et al., The CEPAC-International investigators include: Massachusetts General Hospital, Harvard Medical School Hospital

C. Hospitalier-de-tourcoing, C. Danel, N. Thérèse, E. Dri-yoman, R. Messou et al., University of Cape Town (Cape Town, South Africa): Robin Wood, Y.R. Gaitonde Centre for AIDS Research & Education Perinatal HIV Research Unit, WITS Health Consortium

A. , D. Paltiel, and E. Kaf, Author Contributions ICMJE criteria for authorship read and met: Agree with the manuscript's results and conclusions: Designed the experiments/the study: EL HT XA FD. Analyzed the data: EL RPW KAF Collected data/did experiments for the study: HT XA. Wrote the first draft of the paper: EL HT, Conducted model analyses: LMU. Assisted in model development and updating: ADP. Provided methodologic guidance and helped developed the model: MCW. Co-developed the model

R. 1. Seyler, C. Anglaret, X. Dakoury-dogbo, N. Messou, E. Toure et al., Medium-term survival, morbidity and immunovirological evolution in HIVinfected adults receiving antiretroviral therapy, Antivir Ther, vol.8, pp.385-393, 2003.

C. Akileswaran, M. Lurie, T. Flanigan, and K. Mayer, Lessons Learned from Use of Highly Active Antiretroviral Therapy in Africa, Clinical Infectious Diseases, vol.41, issue.3, pp.376-385, 2005.
DOI : 10.1086/431482

L. Ivers, D. Kendrick, and K. Doucette, Efficacy of Antiretroviral Therapy Programs in Resource???Poor Settings: A Meta???analysis of the Published Literature, Clinical Infectious Diseases, vol.41, issue.2, pp.217-224, 2005.
DOI : 10.1086/431199

P. Sow, L. Otieno, E. Bissagnene, C. Kityo, and R. Bennink, Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.3, pp.262-267, 2007.
DOI : 10.1097/QAI.0b013e31802bf109

R. Hammond and T. Harry, Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures - a meta-analysis, International Journal of STD & AIDS, vol.19, issue.5, 2008.
DOI : 10.1258/ijsa.2007.007248

L. Bekker, L. Myer, C. Orrell, S. Lawn, and R. Wood, Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, S Afr Med J, vol.96, pp.315-320, 2006.

L. Ferradini, A. Jeannin, L. Pinoges, J. Izopet, and D. Odhiambo, Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1342, 2006.
DOI : 10.1016/S0140-6736(06)68580-2

J. Stringer, I. Zulu, J. Levy, E. Stringer, and A. Mwango, Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in Zambia, JAMA, vol.296, issue.7, pp.782-793, 2006.
DOI : 10.1001/jama.296.7.782

B. Ojikutu, A. Makadzange, and T. Gaolathe, Scaling up ART treatment capacity: Lessons learned from South Africa, Zimbabwe, and Botswana, Current HIV/AIDS Reports, vol.83, issue.2, pp.94-98, 2008.
DOI : 10.1007/s11904-008-0015-3

S. Toure, B. Kouadio, C. Seyler, M. Traore, and N. Dakoury-dogbo, Rapid scaling-up of antiretroviral therapy in 10 000 adults in C??te d??Ivoire: 2-year outcomes and determinants, AIDS, vol.22, issue.7, pp.873-882, 2008.
DOI : 10.1097/QAD.0b013e3282f768f8

W. Unicef, Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector, Progress Report, 2008.

P. Braitstein, M. Brinkhof, F. Dabis, M. Schechter, and A. Boulle, Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, pp.817-824, 2006.

S. Rosen, M. Fox, and C. Gill, Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review, PLoS Medicine, vol.44, issue.10, 2007.
DOI : 10.1371/journal.pmed.0040298.sd001

C. Laurent, H. Meilo, J. Guiard-schmid, Y. Mapoure, and J. Noel, Antiretroviral Therapy in Public and Private Routine Health Care Clinics in Cameroon: Lessons from the Douala Antiretroviral (DARVIR) Initiative, Clinical Infectious Diseases, vol.41, issue.1, pp.108-111, 2005.
DOI : 10.1086/430712

S. Lawn, L. Myer, G. Harling, C. Orrell, and L. Bekker, Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation, Clinical Infectious Diseases, vol.43, issue.6, pp.770-776, 2006.
DOI : 10.1086/507095

J. Van-oosterhout, N. Bodasing, J. Kumwenda, C. Nyirenda, and J. Mallewa, Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi, Tropical Medicine and International Health, vol.43, issue.2, pp.464-470, 2005.
DOI : 10.1016/S0140-6736(02)09330-3

K. Wools-kaloustian, S. Kimaiyo, L. Diero, A. Siika, and J. Sidle, Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya, AIDS, vol.20, issue.1, pp.41-48, 2006.
DOI : 10.1097/01.aids.0000196177.65551.ea

D. Brown, J. Thorne, G. Foster, J. Duncan, and L. Brune, Factors affecting attrition in a longitudinal study of patients with AIDS, AIDS Care, vol.18, issue.7, pp.821-829, 2006.
DOI : 10.1080/09540120500466747

G. Touloumi, S. Pocock, A. Babiker, and J. Darbyshire, Impact of Missing Data Due to Selective Dropouts in Cohort Studies and Clinical Trials, Epidemiology, vol.13, issue.3, pp.347-355, 2002.
DOI : 10.1097/00001648-200205000-00017

X. Anglaret, S. Toure, G. Gourvellec, A. Tchehy, and L. Zio, Impact of Vital Status Investigation Procedures on Estimates of Survival in Cohorts of HIV-Infected Patients From Sub-Saharan Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.3, pp.320-323, 2004.
DOI : 10.1097/00126334-200403010-00015

G. Bisson, T. Gaolathe, R. Gross, C. Rollins, and S. Bellamy, Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts, PLoS ONE, vol.147, issue.3, 2008.
DOI : 10.1371/journal.pone.0001725.t003

R. Dalal, C. Macphail, M. Mqhayi, J. Wing, and C. Feldman, Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa, J Acquir Immune Defic Syndr, vol.47, pp.101-107, 2008.

M. Maskew, P. Macphail, C. Menezes, and D. Rubel, Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy, S Afr Med J, vol.97, pp.853-857, 2007.

J. Yu, S. Chen, K. Wang, C. Chang, and S. Makombe, True outcomes for patients on antiretroviral therapy who are ''lost to follow-up'' in Malawi, Bull World Health Organ, vol.85, pp.550-554, 2007.

S. Goldie, A. Paltiel, M. Weinstein, E. Losina, and G. Seage, Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection, The American Journal of Medicine, vol.115, issue.8, pp.632-641, 2003.
DOI : 10.1016/j.amjmed.2003.07.007

K. Freedberg, E. Losina, M. Weinstein, A. Paltiel, and C. Cohen, The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease, New England Journal of Medicine, vol.344, issue.11, pp.824-831, 2001.
DOI : 10.1056/NEJM200103153441108

A. Paltiel, M. Weinstein, A. Kimmel, G. Seage, and E. Losina, Expanded Screening for HIV in the United States ??? An Analysis of Cost-Effectiveness, New England Journal of Medicine, vol.352, issue.6, pp.586-595, 2005.
DOI : 10.1056/NEJMsa042088

M. Weinstein, S. Goldie, E. Losina, C. Cohen, and J. Baxter, Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness, Annals of Internal Medicine, vol.134, issue.6, pp.440-450, 2001.
DOI : 10.7326/0003-4819-134-6-200103200-00008

M. Gold, J. Siegel, L. Russell, and M. Weinstein, Cost effectiveness in health and medicine, 1996.

E. Losina, X. Anglaret, Y. Yazdanpanah, B. Wang, and S. Toure, Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Cote d'Ivoire, S Afr Med J, vol.96, pp.526-529, 2006.

A. Minga, C. Danel, Y. Abo, L. Dohoun, and D. Bonard, Progression to WHO criteria for starting antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Cote d'Ivoire, Bulletin of the World Health Organization, vol.85, issue.2, pp.116-123, 2007.
DOI : 10.2471/BLT.06.032292

E. Losina, Y. Yazdanpanah, S. Deuffic-burban, B. Wang, and L. Wolf, The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Cote d'Ivoire, Antivir Ther, vol.12, pp.543-551, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00200067

S. Goldie, Y. Yazdanpanah, E. Losina, M. Weinstein, and X. Anglaret, Cost-Effectiveness of HIV Treatment in Resource-Poor Settings ??? The Case of C??te d'Ivoire, New England Journal of Medicine, vol.355, issue.11, pp.1141-1153, 2006.
DOI : 10.1056/NEJMsa060247

Y. Yazdanpanah, E. Losina, X. Anglaret, S. Goldie, and R. Walensky, Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in C??te d???Ivoire: a trial-based analysis, AIDS, vol.19, issue.12, pp.1299-1308, 2005.
DOI : 10.1097/01.aids.0000180101.80888.c6

F. Dabis, E. Balestre, P. Braitstein, P. Miotti, and W. Brinkhof, Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts, Int J Epidemiol, vol.34, pp.979-986, 2005.

C. Danel, R. Moh, A. Anzian, Y. Abo, and H. Chenal, Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.1, pp.29-35, 2006.
DOI : 10.1097/01.qai.0000219777.04927.50

R. Mata, P. Viciana, A. De-alarcon, L. Lopez-cortes, and J. Gomez-vera, Discontinuation of Antiretroviral Therapy in Patients with Chronic HIV Infection: Clinical, Virologic, and Immunologic Consequences, AIDS Patient Care and STDs, vol.19, issue.9, pp.550-562, 2005.
DOI : 10.1089/apc.2005.19.550

J. Mellors, A. Munoz, J. Giorgi, J. Margolick, and C. Tassoni, Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-954, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003

A. Mocroft, O. Kirk, P. Aldins, A. Chies, and A. Blaxhult, Loss to follow-up in an international, multicentre observational study, HIV Medicine, vol.35, issue.5, pp.261-269, 2008.
DOI : 10.1056/NEJMoa062360

A. Beaulière, A. Pouhé, H. Touré, X. Anglaret, and F. Dabis, Access to care for people living with HIV/AIDS: assessing the financial burden in Côte d'Ivoire, ANRS 12137 Study, Oral Presentation, December 5, Session (SOE05); Costs of treatment and care, 15th International Conference on AIDS and STIs in Africa (ICASA), pp.3-7, 2008.

N. Nombela, B. Kouadio, S. Toure, C. Seyler, and Y. Flori, Nonantiretroviral Drug Consumption by CD4 Cell Count in HIV-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.2, pp.225-231, 2006.
DOI : 10.1097/01.qai.0000179456.39185.9b

M. Sans and F. , Untangling the web of antiretroviral price reductions Available: http://www.msfaccess.org, 2008.

M. Forster, C. Bailey, M. Brinkhof, C. Graber, and A. Boulle, Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings, Bull World Health Organ, vol.86, pp.939-947, 2008.

M. Brinkhof, F. Dabis, L. Myer, D. Bangsberg, and A. Boulle, Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lowerincome countries, Bull World Health Organ, vol.86, pp.559-567, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00182959

C. Gilks, S. Crowley, R. Ekpini, S. Gove, and J. Perriens, The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings, The Lancet, vol.368, issue.9534, pp.505-510, 2006.
DOI : 10.1016/S0140-6736(06)69158-7

G. Bisson, I. Frank, R. Gross, V. Lo-re, and J. Strom, Out-of-pocket costs of HAART limit HIV treatment responses in Botswana??s private sector, AIDS, vol.20, issue.9, pp.1333-1336, 2006.
DOI : 10.1097/01.aids.0000232245.36039.2b

H. Ramadhani, N. Thielman, K. Landman, E. Ndosi, and F. Gao, Predictors of Incomplete Adherence, Virologic Failure, and Antiviral Drug Resistance among HIV-Infected Adults Receiving Antiretroviral Therapy in Tanzania, Clinical Infectious Diseases, vol.45, issue.11, pp.1492-1498, 2007.
DOI : 10.1086/522991

S. Boyer, F. Marcellin, P. Ongolo-zogo, S. Abega, and R. Nantchouang, Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey, Bulletin of the World Health Organization, vol.87, issue.4, pp.279-287, 2009.
DOI : 10.2471/BLT.07.049643

R. Zachariah, I. Van-engelgem, M. Massaquoi, L. Kocholla, and M. Manzi, Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.102, issue.3, pp.288-293, 2008.
DOI : 10.1016/j.trstmh.2007.12.007

N. Brikci and M. Philips, User fees or equity funds in low-income countries, The Lancet, vol.369, issue.9555, pp.10-11, 2007.
DOI : 10.1016/S0140-6736(07)60008-7

G. Djohan, A. Kouakoussui, and P. Msellati, [Direct cost related to management and care provision for HIV-infected children in the asymptomatic stage in Abidjan, pp.627-636, 2005.

R. Zachariah, A. Harries, M. Manzi, P. Gomani, and R. Teck, Acceptance of Anti-Retroviral Therapy among Patients Infected with HIV and Tuberculosis in Rural Malawi Is Low and Associated with Cost of Transport, PLoS ONE, vol.7, issue.1, 2006.
DOI : 10.1371/journal.pone.0000121.t001

C. Boileau, V. Nguyen, M. Sylla, N. Machouf, and A. Chamberland, Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.4, pp.476-484, 2008.
DOI : 10.1097/QAI.0b013e31817dc416

J. Mamlin, S. Kimaiyo, S. Lewis, H. Tadayo, and F. Jerop, Integrating Nutrition Support for Food-Insecure Patients and Their Dependents Into an HIV Care and Treatment Program in Western Kenya, American Journal of Public Health, vol.99, issue.2, pp.215-221, 2008.
DOI : 10.2105/AJPH.2008.137174

P. Braitstein, A. Siika, J. Hogan, R. Kosgei, and E. Sang, High risk express care: a novel care model to reduce early mortality among high risk HIV-infected patients initiating combination antiretroviral treatment, Proceedings of the 2009 HIV/AIDS Implementer's Meeting, 2009.